Entrada Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 4.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 158.65M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was f...